Novel antiviral agents: phosphoramidates or mono/di/tri-phosphate esters of carbocyclic adenosine analogues: Expert Opinion on Therapeutic Patents: Vol 11, No 2

Views

CrossRef citations to date

Altmetric

Abstract

The patent application describes new compounds, their preparation processes and methods for their use in treating viral infections (particularly hepatitis B) and retroviral infections (particularly HIV). The anti-HIV activity in MT₄ cells is claimed to be in the range pM to μM.

Keywords

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Novel antiviral agents: phosphoramidates or mono/di/tri-phosphate esters of carbocyclic adenosine analogues

Information for

Open access

Opportunities

Help and information

Novel antiviral agents: phosphoramidates or mono/di/tri-phosphate esters of carbocyclic adenosine analogues

Abstract

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature